BRIEF-Repros Therapeutics reports Q1 loss per share of $0.20

* Repros therapeutics inc. reports first quarter 2016 financial results
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.